topic

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab
Cathrine Lund Lorentzen, Julie Westerlin Kjeldsen, Eva Ehrnrooth, Mads Hald Andersen, Inge Marie Svane

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006755; DOI: 10.1136/jitc-2023-006755
Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study
Jianli Zhao, Zhixian Sun, Yunfang Yu, Zhongyu Yuan, Ying Lin, Yujie Tan, Xiaohui Duan, Herui Yao, Ying Wang, Jieqiong Liu

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006514; DOI: 10.1136/jitc-2022-006514
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development
Cong Zhang, Sisi Wei, Suli Dai, Xiaoya Li, Huixia Wang, Hongtao Zhang, Guogui Sun, Baoen Shan, Lianmei Zhao

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006230; DOI: 10.1136/jitc-2022-006230
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets
Vladimir Laletin, Pierre-Louis Bernard, Cathy Costa da Silva, Geoffrey Guittard, Jacques A Nunes

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e005845; DOI: 10.1136/jitc-2022-005845
Extending the conversation over the immune-related hepatotoxicity: author response to Dr. Gauci et al
Dimitrios C Ziogas, Helen Gogas

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e002391; DOI: 10.1136/jitc-2021-002391
Efficacy of immune checkpoint inhibitors for in-transit melanoma
Emilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, Lumine Na, James Bozzi, Tavis Read, Victoria Atkinson, George Au-Yeung, Georgina V Long, Grant A McArthur, Shahneen Sandhu, Robyn Saw, Euan Walpole, Alexander Menzies, Mark Smithers, David E Gyorki

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000440; DOI: 10.1136/jitc-2019-000440
Immune checkpoint inhibitor-associated celiac disease
Yousef R Badran, Angela Shih, Donna Leet, Meghan J Mooradian, Alexandra Coromilas, Jonathan Chen, Marina Kem, Hui Zheng, Jennifer Borowsky, Joseph Misdraji, Mari Mino-Kenudson, Michael Dougan

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000958; DOI: 10.1136/jitc-2020-000958
Chronic immune checkpoint inhibitor pneumonitis
Jarushka Naidoo, Tricia R Cottrell, Evan J Lipson, Patrick M Forde, Peter B Illei, Lonny B Yarmus, K Ranh Voong, David Feller-Kopman, Hans Lee, Joanne Riemer, Daphne Wang, Janis M Taube, Julie R Brahmer, Cheng Ting Lin, Sonye K Danoff, Franco R D'Alessio, Karthik Suresh

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000840; DOI: 10.1136/jitc-2020-000840
MRI of tumor T cell infiltration in response to checkpoint inhibitor therapy
Xiaoyu Jiang, Stephanie Dudzinski, Kathryn E Beckermann, Kirsten Young, Eliot McKinley, J Oliver McIntyre, Jeffrey C Rathmell, Junzhong Xu, John C Gore

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000328; DOI: 10.1136/jitc-2019-000328
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
Lin Shen, Jun Guo, Qingyuan Zhang, Hongming Pan, Ying Yuan, Yuxian Bai, Tianshu Liu, Qing Zhou, Jun Zhao, Yongqian Shu, Xiaoming Huang, Siyang Wang, Jie Wang, Aiping Zhou, Dingwei Ye, Ting Sun, Yujuan Gao, Silu Yang, Zuobai Wang, Jian Li, Yi-Long Wu

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000437; DOI: 10.1136/jitc-2019-000437

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages